Ardent Health Partners, Inc. (NYSE:ARDT) reported fourth-quarter earnings that surpassed analyst expectations, driven by strong revenue growth and the retroactive approval of a state payment program. The healthcare provider’s shares jumped 5.3% following the announcement and positive 2025 outlook.
Ardent Health reported fourth-quarter adjusted earnings per share of $0.81 on revenue of $1.61 billion, representing a 19% YoY increase. The company’s performance was bolstered by a 9.0% rise in adjusted admissions and a 9.5% growth in net patient service revenue per adjusted admission.
A key factor in the quarter’s success was the retroactive approval of the New Mexico state directed payment program, which contributed $94 million to total revenue and $65 million to Adjusted EBITDA. Excluding this benefit, the company’s performance remained in line with or favorable to its 2024 guidance.
Looking ahead, Ardent Health provided an optimistic outlook for 2025, projecting revenue between $6.2 billion and $6.45 billion, with the midpoint slightly above the analyst consensus of $6.3 billion. The company expects Adjusted EBITDA to grow by 19% at the midpoint of its guidance range.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.